Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Low Sensitivity to Thrombomodulin Correlates with Liver Stiffness in Advanced Chronic Liver Disease

Justine Brodard, Sara Calzavarini, PhD, Andrea de Gottardi, Anne Angelillo-Scherrer, MD PhD

Blood (2019) 134 (Supplement_1): 4948.

https://doi.org/10.1182/blood-2019-132251

Published: 2019

Journal Articles

A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloidosis

Larysa Sanchez, MD, Heather J Landau, MD, Cara A. Rosenbaum, MD, Alex Abrahams, Cindy Chin, Brielle Liotta, BS, Natalie Agudo, RN, Sheetal Ramnath, Elizabeth Hoover, BS, Hafsa Rahman, Umut Ozbek, PhD, Oscar B Lahoud, MD, Hani Hassoun, MD, Keren Osman, MD

Blood (2019) 134 (Supplement_1): 3128.

https://doi.org/10.1182/blood-2019-126023

Published: 2019

Journal Articles

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome

Mira T Tanenbaum, BA, Anna Shvygina, BS, Vaishnavi Sridhar, BS, Jennifer E. Vaughn, MD MSPH, Mark Joseph, MD

Blood (2019) 134 (Supplement_1): 4854.

https://doi.org/10.1182/blood-2019-131561

Published: 2019

Journal Articles

Sublingual Microcirculatory Imaging As a Novel Tool to Monitor for Cytokine Release Syndrome after Chimeric Antigen Receptor T-Cell Therapy

Andrew Deitchman, MD, Michael McCurdy, MD, Muhammad Gilani, MBBS, Aaron P. Rapoport, MD, Kathleen Ruehle, RN, Nancy M. Hardy, MD, Elizabeth Hutnick, RN, Jean Yared, MD, Saurabh Dahiya, MD

Blood (2018) 132 (Supplement 1): 5408.

https://doi.org/10.1182/blood-2018-99-115393

Published: 2018

Journal Articles

Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis

Christoph Kimmich, MD, Stefan Schönland, MD, Rita Ziehl, Anthony D. Ho, Tobias Dittrich, MD, Carsten Müller-Tidow, Ute Hegenbart

Blood (2017) 130 (Supplement 1): 1837.

https://doi.org/10.1182/blood.V130.Suppl_1.1837.1837

Published: 2017

Journal Articles

Retrospective Study of High Hemoglobin Levels in 56 Young Adults

Alexandra Desnoyers, MD, Michel Pavic, MD, Jean-Francois Castilloux, MD, Patrice Beauregard, MD FRCPC., Line Delisle, MD, Richard Le Blanc, MD PhD, Jean Dufresne, MD, Josie-Anne Boisjoly, MD, Vincent Ethier, MDBSc

Blood (2016) 128 (22): 1262.

https://doi.org/10.1182/blood.V128.22.1262.1262

Published: 2016

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Undergoing Major Cardiac Surgery

Deepa Jayakody Arachchillage, Simona Deplano, Eleanor Dunnett, Steve Owen, Louise Tillyer, Michael Laffan

Blood (2016) 128 (22): 3852.

https://doi.org/10.1182/blood.V128.22.3852.3852

Published: 2016

Journal Articles

Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)

Blood (2016) 128 (22): 1939.

https://doi.org/10.1182/blood.V128.22.1939.1939

Published: 2016

Journal Articles

Bridging Therapy with Sodium Bemiparin at Therapeutic-Dose: Experience in Our Hospital

Almudena Garcia Ruiz, DOCTOR, Estefania Morente Constatin, MDCINE RESIDENT, Pablo Romero Garcia, MDCINE RESIDENT, Margarita Gomez Morales, DOCTOR AND HEMATOLOGIST, Manuel Jurado, MD

Blood (2016) 128 (22): 5019.

https://doi.org/10.1182/blood.V128.22.5019.5019

Published: 2016

Journal Articles

A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis

Frank Stegelmann, MD, Markus Bangerter, MD, Florian H Heidel, MD, Martin Griesshammer, MD, Holger Hebart, MD, Andreas Hochhaus, MD, Steffen Koschmieder, MD, Robert Möhle, MD, Andreas Reiter, MD, Christof Scheid, MD PhD, Rebecca Kirschbaum, Regina Reim, Ulrike Sutter, Katrin Vetter, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD

Blood (2015) 126 (23): 826.

https://doi.org/10.1182/blood.V126.23.826.826

Published: 2015

Journal Articles

Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 1b Results

Philippe Moreau, MD PhD, Asher Chanan-Khan, MD, Andrew W. Roberts, MBBS, PhD, Amit B. Agarwal, MDPhD, Thierry Facon, Shaji Kumar, MD, Cyrille Touzeau, MD, David Darden, MS, Lura Morris, BA, Jeremy Ross, PhD, Ahmed H Salem, PhD, Wijith Munasinghe, PhD, Ming Zhu, PhD, Joel Leverson, PhD, Paulo Maciag, MD, Sari Heitner Enschede, MD, Maria Verdugo, MD, Rod A. Humerickhouse, MD PhD, Simon Harrison, MD

Blood (2015) 126 (23): 3038.

https://doi.org/10.1182/blood.V126.23.3038.3038

Published: 2015

Journal Articles

A Multicenter Phase-Ib/II Study of Ruxolitinib/Pomalidomide Combination Therapy in Patients with Primary and Secondary Myelofibrosis: Safety Data from the Mpnsg-0212 Trial (NCT01644110)

Frank Stegelmann, MD, Martin Griesshammer, Andreas Reiter, MD, Andreas Hochhaus, MD, Florian H Heidel, MD, Cora Heiligensetzer, Ulrike Sutter, Regina Reim, Stefanie Schauer, Rebecca Kirschbaum, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD

Blood (2014) 124 (21): 3161.

https://doi.org/10.1182/blood.V124.21.3161.3161

Published: 2014

Journal Articles

Spleen Stiffness Measurement By Transient Elastography As a Predictor of Bone Marrow Fibrosis in Primary Myelofibrosis Patients

Alessandra Iurlo, MD PhD, Daniele Cattaneo, MD, Mariangela Giunta, MD, Umberto Gianelli, MD, Giovanni Casazza, MD, Mirella Fraquelli, MD PhD, Nicola Orofino, MD, Cristina Bucelli, MD, Paola Bianchi, BSC, PhD, Claudia Augello, BSC, PhD, Silvano Bosari, MD, Massimo Colombo, MD, Agostino Cortelezzi, MD

Blood (2014) 124 (21): 1825.

https://doi.org/10.1182/blood.V124.21.1825.1825

Published: 2014

Journal Articles

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW

Blood (2012) 120 (21): 716.

https://doi.org/10.1182/blood.V120.21.716.716

Published: 2012

Journal Articles

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

Tomer M Mark, MD, MSc, Whitney Reid, Ruben Niesvizky, MD, Usama Gergis, MD, Roger N Pearse, MD, PhD, Sebastian Mayer, MD, Morton Coleman, MD, Eric J Feldman, MD, Tsiporah B. Shore, MD

Blood (2011) 118 (21): 2042.

https://doi.org/10.1182/blood.V118.21.2042.2042

Published: 2011

Journal Articles

Efficacy of Bortezomib/Cyclophosphamide/Dexamethasone (VCD) Chemotherapy In Naive Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Arnaud Jaccard, Murielle Roussel, Anne Banos, David Lavergne, Jacques Ninet, Bertrand Arnulf, MD, PhD, Dominique Bordessoule, Frank Bridoux, Jean Paul Fermand, MD

Blood (2011) 118 (21): 5126.

https://doi.org/10.1182/blood.V118.21.5126.5126

Published: 2011

Journal Articles

Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis

Ayalew Tefferi, MD, Kebede Begna, MD, William J Hogan, MBBCh, Mark R. Litzow, MD, Curtis A Hanson, Animesh Pardanani, MBBS, PhD

Blood (2011) 118 (21): 1752.

https://doi.org/10.1182/blood.V118.21.1752.1752

Published: 2011

Journal Articles

Efficacy and Toxicity of Dose-Reduced Bortezomib/Dexamethasone Chemotherapy In Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Stefan O Schonland, MD, Tilmann Bochtler, MD, Anthony D. Ho, MD, Ute Hegenbart, MD

Blood (2010) 116 (21): 1960.

https://doi.org/10.1182/blood.V116.21.1960.1960

Published: 2010

Journal Articles

Role of Protein Disulfide Isomerase (PDI) In the Expression of Tissue Factor (TF) Procoagulant Activity on Apoptotic Myeloblasts

Brigitte Spath, Ali Amirkhosravi, PhD, Monica Davila, PhD, John L. Francis, PhD, Barbara Eifrig, MD, Carsten Bokemeyer, MD, Florian Langer, MD

Blood (2010) 116 (21): 152.

https://doi.org/10.1182/blood.V116.21.152.152

Published: 2010

Journal Articles

A Study of Factors Influencing Outcome In Patients with Haematological Malignancy Requiring High Dependency Support In a Large UK Haematology and Bone Marrow Transplant Centre

Satarupa Choudhuri, Tim Somervaille, Phil Haji Michael, Mike Dennis

Blood (2010) 116 (21): 4732.

https://doi.org/10.1182/blood.V116.21.4732.4732

Published: 2010

NARROW

Low Sensitivity to Thrombomodulin Correlates with Liver Stiffness in Advanced Chronic Liver Disease

A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloidosis

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome

Sublingual Microcirculatory Imaging As a Novel Tool to Monitor for Cytokine Release Syndrome after Chimeric Antigen Receptor T-Cell Therapy

Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis

Retrospective Study of High Hemoglobin Levels in 56 Young Adults

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Undergoing Major Cardiac Surgery

Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)

Bridging Therapy with Sodium Bemiparin at Therapeutic-Dose: Experience in Our Hospital

A Phase-Ib/II Study of Ruxolitinib Plus Pomalidomide in Myelofibrosis

Safety and Efficacy of Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase 1b Results

A Multicenter Phase-Ib/II Study of Ruxolitinib/Pomalidomide Combination Therapy in Patients with Primary and Secondary Myelofibrosis: Safety Data from the Mpnsg-0212 Trial (NCT01644110)

Spleen Stiffness Measurement By Transient Elastography As a Predictor of Bone Marrow Fibrosis in Primary Myelofibrosis Patients

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW

A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplant in Multiple Myeloma

Efficacy of Bortezomib/Cyclophosphamide/Dexamethasone (VCD) Chemotherapy In Naive Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis

Efficacy and Toxicity of Dose-Reduced Bortezomib/Dexamethasone Chemotherapy In Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Role of Protein Disulfide Isomerase (PDI) In the Expression of Tissue Factor (TF) Procoagulant Activity on Apoptotic Myeloblasts

A Study of Factors Influencing Outcome In Patients with Haematological Malignancy Requiring High Dependency Support In a Large UK Haematology and Bone Marrow Transplant Centre

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only